QUOTED. 10 May 2019. Mike Roman.
Executive Summary
Industrial conglomerate 3M is paying $6.7bn to buy Acelity LP and its KCI subsidiaries in an ambitious move to expand its presence in the wound-care market. See what 3M CEO Mike Roman said about it here.
"Today, our advanced wound-care technologies include solutions that prevent the formation of wounds, prepare the wound for the beginning of the healing process and protect the wound while it heals. This acquisition will help us to build out these solutions and expand our offerings, enabling us to provide greater value across the entire care pathway for patients and healthcare providers. It will also allow us to apply our fundamental strengths to create unique value, especially around our global reach and technology development." – Mike Roman, CEO, 3M
Click here for a free trial of Medtech Insight